IL6 and breast carcinoma: Indeed, sympathetic stimulus has been described to increase IL-6 levels in MDA-231 breast cancer cells with high β-adrenergic receptor (β-AR) expression [44] and both MDA-1833 and human osteoclasts express several ARs, being therefore responsive to sympathetic stimuli (Fig. S4).